Multiple sclerosis trials in Ukraine
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Where
- Chernivtsi, Ivano-Frankivsk, Lviv, Vinnytsia
- Age
- 18 years to 60 years
- People
- 705 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07067463 · EU 2025-524316-11-00 - Phase 2Taking peopleA Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
- Where
- Lviv
- Age
- 10 years to 17 years
- People
- 12 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07161258 · EU 2024-519800-28-00 - Phase 3Taking peopleA Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Where
- Chernivtsi, Ivano-Frankivsk, Lviv, Vinnytsia
- Age
- 18 years to 60 years
- People
- 990 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07299019 · EU 2025-524322-18-00 - Phase 2Taking peopleA Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)
- Where
- Chernihiv, Ivano-Frankivsk, Kyiv, Lviv, Odesa, Poltava, Ternopil, Uzhhorod, Vinnytsia
- Age
- 18 years to 65 years
- People
- 350 worldwide
- Run by
- TG Therapeutics, Inc.
See details and how to joinNCT07503873 · EU 2025-523757-33-00 - Phase 3Taking peopleAn Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
- Where
- Cherkasy, Chernihiv, Chernivtsi, Dnipro, Ivano-Frankivsk, Kharkiv, Kyiv, Lutsk, Lviv, Vinnytsi, Zaporizhzhya
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06675955 · EU 2023-507633-21-01